| 5 mins | 30 mins | Hourly | Daily | Weekly |
|---|---|---|---|---|
| NEUTRAL | BUY | BUY | BUY | BUY |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MA5 | 17.06▼ | 17.01▲ | 16.80▲ | 16.12▲ | 15.47▲ |
| MA10 | 17.05▼ | 16.80▲ | 16.46▲ | 15.63▲ | 15.62▲ |
| MA20 | 17.06▼ | 16.47▲ | 16.22▲ | 15.23▲ | 15.06▲ |
| MA50 | 16.85▲ | 16.04▲ | 15.64▲ | 15.53▲ | 15.07▲ |
| MA100 | 16.48▲ | 15.61▲ | 15.41▲ | 14.87▲ | 34.85▼ |
| MA200 | 16.28▲ | 15.39▲ | 15.39▲ | 13.64▲ | 38.55▼ |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MACD | -0.021▼ | 0.059▲ | 0.082▲ | 0.202▲ | 0.512▲ |
| RSI | 55.535▲ | 72.118▲ | 72.851▲ | 69.504▲ | 54.839▲ |
| STOCH | 43.791 | 88.174▲ | 70.055 | 78.917 | 60.562 |
| WILL %R | -66.667 | -10.373▲ | -9.766▲ | -5.123▲ | -3.209▲ |
| CCI | -41.854 | 74.124 | 140.096▲ | 230.031▲ | 188.480▲ |
|
Sunday, November 09, 2025 04:48 AM
Keros Therapeutics, Inc. ( NASDAQ:KROS ) defied analyst predictions to release its quarterly results, which were ...
|
|
Wednesday, November 05, 2025 11:05 AM
LEXINGTON, Mass., Nov. 05, 2025 (GLOBE NEWSWIRE) -- (“Keros” or the “Company”) (Nasdaq: KROS), a clinical-stage biopharmaceutical company focused on developing and commercializing novel therapeutics ...
|
|
Sunday, October 19, 2025 10:00 PM
Detailed price information for Keros Therapeutics Inc (KROS-Q) from The Globe and Mail including charting and trades.
|
| date | open | high | low | close | volume |
|---|---|---|---|---|---|
| 10/11/25 | 16.63 | 17.175 | 16.575 | 17.05 | 867,237 |
| 07/11/25 | 16.24 | 16.75 | 15.89 | 16.20 | 1,327,824 |
| 06/11/25 | 16.13 | 16.62 | 15.65 | 16.17 | 1,787,628 |
| 05/11/25 | 15.52 | 15.69 | 15.15 | 15.65 | 1,262,334 |
| 04/11/25 | 15.10 | 15.665 | 15.10 | 15.55 | 1,140,613 |
| 03/11/25 | 15.05 | 15.24 | 14.855 | 15.22 | 881,329 |
| 31/10/25 | 15.05 | 15.295 | 14.86 | 15.22 | 666,202 |
| 30/10/25 | 15.00 | 15.29 | 14.96 | 15.03 | 1,038,240 |
| 29/10/25 | 15.15 | 15.47 | 15.00 | 15.04 | 997,750 |
| 28/10/25 | 14.90 | 15.44 | 14.77 | 15.18 | 960,603 |
|
|
||||
|
|
||||
|
|